Skip to main content

Table 3 Treatment characteristics of EWS patients

From: Survival and treatment in older patients with ewing sarcoma: an analysis of the national cancer database

Variable

Unmatched

p-value

Propensity score (1:1) matched

p-value

Patients ≤ 40 (n = 4058)

Patients > 40 (n = 542)

Patients ≤ 40 (n = 542)

Patients > 40 (n = 542)

Surgery of primary site, n (%)

 Surgery of primary site performed

2102 (51.8)

253 (46.7)

0.025

268 (49.4)

253 (46.7)

0.362

 Surgery of primary site not performed

1956 (48.2)

289 (53.3)

274 (50.6)

289 (53.3)

Surgical margins, n (%)

 No residual tumor

1456 (35.9)

146 (26.9)

< 0.001

179 (33.0)

146 (26.9)

0.121

 Microscopic residual tumor

96 (2.4)

13 (2.4)

14 (2.6)

13 (2.4)

 Macroscopic residual tumor

47 (1.2)

12 (2.2)

5 (0.9)

12 (2.2)

 Surgical margins unknown

96 (2.4)

16 (3.0)

15 (2.8)

16 (3.0)

Palliative care n (%)

 Received

168 (4.1%)

42 (7.7%)

< 0.001

28 (5.2)

42 (7.7)

0.084

 Did not receive

3890 (95.9%)

500 (92.3%)

514 (94.8)

500 (92.3)

Adjuvant therapy, n (%)

 Adjuvant chemotherapy

1826 (96.2%)

198 (93.4%)

0.039

234 (97.9)

198 (93.4)

0.017

 Adjuvant radiation

14 (0.7%)

5 (2.4%)

0 (0.0)

5 (2.4)

 Adjuvant chemoradiation

58 (3.1%)

9 (4.2%)

5 (2.1)

9 (4.2)

Time to surgery (mean days (SD))

99.0 (69.1)

85.6 (89.7)

0.005

102.4 (73.6)

85.6 (89.7)

0.020

Tumor size (mean mm (SD))

510.8 (455.6)

525.7 (459.6)

0.053

518.9 (455.2)

525.7 (459.6)

0.807

Time to initiation of treatment (mean days (SD))

19.2 (29.1)

29.5 (36.7)

< 0.001

18.7 (24.8)

29.5 (36.7)

< 0.001

Time to chemo (mean days (SD))

23.1 (28.4)

46.3 (42.4)

< 0.001

22.8 (26.7)

46.3 (42.4)

< 0.001